Prices delayed by at least 15 minutes | Print
Ocular Therapeutix (OCUL)
Common SharesThis share can be held in a Dealing accountISALifetime ISAJISASIPP
Company profile
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Address
24 Crosby Drive
Bedford
MA
USA
01730
Telephone
+1 877 6288998
Forecast key dates
| Name | Key Date |
|---|---|
| Ocular Therapeutix Inc Fourth Quarter Earnings Conference Call for 2024 | 2025-03-11T16:00:00 |
| Ocular Therapeutix Inc Fourth Quarter Earnings Results for 2024 | 2025-03-11T00:00:00 |
| Ocular Therapeutix Inc Annual Report for 2024 | 2025-03-11T00:00:00 |
| Ocular Therapeutix Inc Third Quarter Earnings Conference Call for 2024 | 2024-11-07T16:30:00 |
| Ocular Therapeutix Inc Third Quarter Earnings Results for 2024 | 2024-11-07T00:00:00 |
| Ocular Therapeutix Inc Second Quarter Earnings Conference Call for 2024 | 2024-08-07T16:30:00 |
| Ocular Therapeutix Inc Second Quarter Earnings Results for 2024 | 2024-08-07T00:00:00 |
| Ocular Therapeutix Inc Annual General Meeting for 2024 | 2024-06-14T08:30:00 |
| Ocular Therapeutix Inc First Quarter Earnings Conference Call for 2024 | 2024-05-08T16:30:00 |
| Ocular Therapeutix Inc First Quarter Earnings Results for 2024 | 2024-05-08T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Ocular Therapeutix Inc Fourth Quarter Earnings Conference Call for 2023 | 2024-03-11T16:00:00 |
| Ocular Therapeutix Inc Annual Report for 2023 | 2024-03-11T00:00:00 |
| Ocular Therapeutix Inc Fourth Quarter Earnings Result for 2023 | 2024-03-11T00:00:00 |
| Ocular Therapeutix Inc Third Quarter Earnings Conference Call for 2023 | 2023-11-07T16:30:00 |
| Ocular Therapeutix Inc Third Quarter Earnings Result for 2023 | 2023-11-07T00:00:00 |
| Ocular Therapeutix Inc Second Quarter Earnings Conference Call for 2023 | 2023-08-07T16:30:00 |
| Ocular Therapeutix Inc Second Quarter Earnings Result for 2023 | 2023-08-07T00:00:00 |
| Ocular Therapeutix Inc Annual General Meeting for 2023 | 2023-06-14T08:30:00 |
| Ocular Therapeutix Inc First Quarter Earnings Conference Call for 2023 | 2023-05-08T16:30:00 |
| Ocular Therapeutix Inc First Quarter Earnings Result for 2023 | 2023-05-08T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.